Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 59, 2024 - Issue 4
Submit an article Journal homepage
867
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Performance and safety of diagnostic EUS FNA/FNB and therapeutic ERCP in patients with borderline resectable and locally advanced pancreatic cancer - results from a population-based, prospective cohort study

Ingvild Farnesa Department of Hepato-Pancreato-Biliary Surgery, Oslo University Hospital, Oslo, Norway;b Institute of Clinical Medicine, University of Oslo, Oslo, NorwayCorrespondence[email protected]
View further author information
,
Vemund Paulsenc Department of Transplantation Medicine, Oslo University Hospital, Oslo, NorwayView further author information
,
Caroline Sofie Verbekeb Institute of Clinical Medicine, University of Oslo, Oslo, Norway;d Department of Pathology, Oslo University HospitalOslo, NorwayView further author information
,
Christer Julseth Tønnesenc Department of Transplantation Medicine, Oslo University Hospital, Oslo, NorwayView further author information
,
Lars Aabakkenb Institute of Clinical Medicine, University of Oslo, Oslo, Norway;c Department of Transplantation Medicine, Oslo University Hospital, Oslo, NorwayView further author information
&
Knut Jørgen Laboria Department of Hepato-Pancreato-Biliary Surgery, Oslo University Hospital, Oslo, Norway;b Institute of Clinical Medicine, University of Oslo, Oslo, NorwayView further author information
Pages 496-502 | Received 07 Oct 2023, Accepted 29 Nov 2023, Published online: 21 Dec 2023

  • Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913–2921. doi: 10.1158/0008-5472.CAN-14-0155
  • Tempero MA, Malafa MP, Al-Hawary M, et al. Pancreatic adenocarcinoma, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(4):439–457. doi: 10.6004/jnccn.2021.0017.
  • Li H, Hu Z, Chen J, et al. Comparison of ERCP, EUS, and ERCP combined with EUS in diagnosing pancreatic neoplasms: a systematic review and meta-analysis. Tumour Biol. 2014;35(9):8867–8874. doi: 10.1007/s13277-014-2154-z.
  • Elhanafi S, Mahmud N, Vergara N, et al. Comparison of endoscopic ultrasound tissue acquisition methods for genomic analysis of pancreatic cancer. J Gastroenterol Hepatol. 2019;34(5):907–913. doi: 10.1111/jgh.14540.
  • Dumonceau JM, Tringali A, Papanikolaou IS, et al. Endoscopic biliary stenting: indications, choice of stents, and results: European society of gastrointestinal endoscopy (ESGE) clinical guideline - updated october 2017. Endoscopy. 2018;50(9):910–930. doi: 10.1055/a-0659-9864.
  • Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av pasienter med pancreaskreft: Helsedirektoratet. 2017 Available from: https://www.helsedirektoratet.no/retningslinjer/pancreaskreft-bukspyttkjertelkreft-handlingsprogram#referere.
  • Board TEbtWCoTE. Digestive system tumours: WHO classification of tumours. 5th ed. Vol 1. World Health Organization; 2019. p. 295–370.
  • Wani S, Muthusamy VR, McGrath CM, et al. AGA white paper: optimizing endoscopic ultrasound–guided tissue acquisition and future directions. Clin Gastroenterol Hepatol. 2018;16(3):318–327. doi: 10.1016/j.cgh.2017.10.020.
  • Cotton PB, Eisen GM, Aabakken L, et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc. 2010;71(3):446–454. doi: 10.1016/j.gie.2009.10.027.
  • Levine I, Trindade AJ. Endoscopic ultrasound fine needle aspiration vs fine needle biopsy for pancreatic masses, subepithelial lesions, and lymph nodes. World J Gastroenterol. 2021;27(26):4194–4207. doi: 10.3748/wjg.v27.i26.4194.
  • Yousri M, Abusinna E, Tahoun N, et al. A comparative study of the diagnostic utility of endoscopic ultrasound-guided fine needle aspiration cytology (EUS-FNA) versus endoscopic ultrasound-guided fine needle biopsy (EUS-FNB) in pancreatic and non-pancreatic lesions. Asian Pac J Cancer Prev. 2022;23(6):2151–2158. doi: 10.31557/APJCP.2022.23.6.2151.
  • Yousaf MN, Chaudhary FS, Ehsan A, et al. Endoscopic ultrasound (EUS) and the management of pancreatic cancer. BMJ Open Gastroenterol. 2020;7(1):e000408. doi: 10.1136/bmjgast-2020-000408.
  • Dumonceau JM, Deprez PH, Jenssen C, et al. Indications, results, and clinical impact of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European society of gastrointestinal endoscopy (ESGE) clinical guideline - updated january 2017. Endoscopy. 2017;49(7):695–714. doi: 10.1055/s-0043-109021.
  • Bang JY, Hebert-Magee S, Trevino J, et al. Randomized trial comparing the 22-gauge aspiration and 22-gauge biopsy needles for EUS-guided sampling of solid pancreatic mass lesions. Gastrointest Endosc. 2012;76(2):321–327. doi: 10.1016/j.gie.2012.03.1392.
  • Tian L, Tang A-L, Zhang L, et al. Evaluation of 22G fine-needle aspiration (FNA) versus fine-needle biopsy (FNB) for endoscopic ultrasound-guided sampling of pancreatic lesions: a prospective comparison study. Surg Endosc. 2018;32(8):3533–3539. doi: 10.1007/s00464-018-6075-6.
  • Chen Y-I, Chatterjee A, Berger R, et al. Endoscopic ultrasound (EUS)-guided fine needle biopsy alone vs. EUS-guided fine needle aspiration with rapid onsite evaluation in pancreatic lesions: a multicenter randomized trial. Endoscopy. 2022;54(1):4–12. doi: 10.1055/a-1375-9775.
  • Kovacevic B, Toxværd A, Klausen P, et al. Tissue amount and diagnostic yield of a novel franseen EUS-FNB and a standard EUS-FNA needle-a randomized controlled study in solid pancreatic lesions. Endosc Ultrasound. 2023;12(3):319–325. doi: 10.1097/eus.0000000000000007.
  • Janssen QP, Quispel R, Besselink MG, et al. Diagnostic performance of endoscopic tissue acquisition for pancreatic ductal adenocarcinoma in the PREOPANC and PREOPANC-2 trials. HPB. 2023;25(10):1161–1168. doi: 10.1016/j.hpb.2023.04.018.
  • Mosele F, Remon J, Mateo J, et al. Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO precision medicine working group. Ann Oncol. 2020;31(11):1491–1505. doi: 10.1016/j.annonc.2020.07.014.
  • Gleeson FC, Kerr SE, Kipp BR, et al. Targeted next generation sequencing of endoscopic ultrasound acquired cytology from ampullary and pancreatic adenocarcinoma has the potential to aid patient stratification for optimal therapy selection. Oncotarget. 2016;7(34):54526–54536. doi: 10.18632/oncotarget.9440.
  • Dreyer SB, Jamieson NB, Evers L, et al. Feasibility and clinical utility of endoscopic ultrasound guided biopsy of pancreatic cancer for next-generation molecular profiling. Chin Clin Oncol. 2019;8(2):16–16. doi: 10.21037/cco.2019.04.06.
  • Izumo W, Higuchi R, Furukawa T, et al. A case of pathologically complete response after preoperative chemotherapy in a pancreatic acinar cell carcinoma patient with portal vein tumor thrombosis. Clin J Gastroenterol. 2022;15(3):642–648. doi: 10.1007/s12328-021-01571-8.
  • Almadi MA, Barkun A, Martel M. Plastic vs. self-expandable metal stents for palliation in malignant biliary obstruction: a series of meta-analyses. Am J Gastroenterol. 2017;112(2):260–273. doi: 10.1038/ajg.2016.512.
  • Uppal DS, Wang AY. Advances in endoscopic retrograde cholangiopancreatography for the treatment of cholangiocarcinoma. World J Gastrointest Endosc. 2015;7(7):675–687. doi: 10.4253/wjge.v7.i7.675.
  • Purnak T, El H, II, Sherman S, et al. Combined versus separate sessions of endoscopic ultrasound and endoscopic retrograde cholangiopancreatography for the diagnosis and management of pancreatic ductal adenocarcinoma with biliary obstruction. Dig Dis Sci. 2021;66(8):2786–2794. doi: 10.1007/s10620-020-06564-0.
  • Jenssen C, Hocke M, Fusaroli P, et al. EFSUMB guidelines on interventional ultrasound (INVUS), part IV – EUS-guided interventions: general aspects and EUS-guided sampling (long version). Ultraschall Med. 2016;37(2):E33–E76. doi: 10.1055/s-0035-1553785.
  • Brown ZJ, Heh V, Labiner HE, et al. Surgical resection rates after neoadjuvant therapy for localized pancreatic ductal adenocarcinoma: meta-analysis. Br J Surg. 2022;110(1):34–42. doi: 10.1093/bjs/znac354.
  • Springfeld C, Ferrone CR, Katz MHG, et al. Neoadjuvant therapy for pancreatic cancer. Nat Rev Clin Oncol. 2023;20(5):318–337. doi: 10.1038/s41571-023-00746-1.
  • Andersson R, Haglund C, Seppanen H, et al. Pancreatic cancer - the past, the present, and the future. Scand J Gastroenterol. 2022;57(10):1169–1177. doi: 10.1080/00365521.2022.2067786.
  • Ratnayake CBB, Roberts KJ, Pandanaboyana S. Upfront surgery vs. neoadjuvant therapy for resectable pancreatic cancer: a narrative review of available evidence. Chin Clin Oncol. 2022;11(1):2–2. doi: 10.21037/cco-21-161.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.